Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial

Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial

Abstract Background Despite the recent advances in cancer treatment, the therapeutic options for patients with biliary tract cancer are still very limited and the prognosis very poor. More than 50% of newly diagnosed patients with biliary tract cancer are not amenable to curative surgical treatment...

Full description

Bibliographic Details
Main Authors: Constantin Schmidt, Antonia Zapf, Ann-Kathrin Ozga, Ali Canbay, Ulrike Denzer, Enrico N. De Toni, Ansgar W. Lohse, Kornelius Schulze, Thomas Rösch, Alexander Stein, Henning Wege, Johann von Felden
Format: Article
Language:English
Published: BMC 2024-08-01
Series:BMC Cancer
Subjects:
Cholangiocarcinoma
CCA
Biliary tract cancer
Klatskin tumor
Biliary ablation
Bile duct stenting
Online Access:https://doi.org/10.1186/s12885-024-12693-w

Internet

https://doi.org/10.1186/s12885-024-12693-w

Similar Items